After years of raising co-payments and deductibles for prescription drugs, some employers are taking an unorthodox approach to lowering health-care costs. Now get this, they are paying for drugs and consultations that go along with them. Larry Boress, president of the Midwest Business Group on Health, tells the Chicago Tribune's Bruce Japsen about this unique approach to controlling prescription spending.
Employers' New Drug Cost Control: Pay for Them!
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
After years of raising co-payments and deductibles for prescription drugs, some employers are taking an unorthodox approach to lowering health-care costs. Now get this, they are paying for drugs and consultations that go along with them. Larry Boress, president of the Midwest Business Group on Health, tells the Chicago Tribune's Bruce Japsen about this unique approach to controlling prescription spending.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
FCS and SHTG: Are We Meeting the Need?
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?